Analyst Price Target is $6,116.00
▲ +15,324.97% Upside Potential
This price target is based on 2 analysts offering 12 month price targets for Croda International in the last 3 months. The average price target is $6,116.00, with a high forecast of $8,800.00 and a low forecast of $80.00. The average price target represents a 15,324.97% upside from the last price of $39.65.
Current Consensus is
The current consensus among 2 investment analysts is to buy stock in Croda International. This rating has held steady since July 2022, when it changed from a Hold consensus rating.
Croda International Plc engages in the manufacture and sale of specialty chemicals. It operates through the following segments: Personal Care, Life Sciences, Performance Technologies and Industrial Chemicals. The Personal Care segment offers speciality sustainable skin care, hair care and solar protection ingredients. The Life Sciences segment includes crop care and healthcare speciality ingredients. The Performance Technologies segment supports the circular economy and durable material design, enabling the growth of clean energy and helping to further reduce negative environmental impact. The Industrial Chemicals segment focuses on its biosurfactant plant at Atlas Point in North America. The company was founded by George Crowe and Henry James Dawe on May 25, 1925 and is headquartered in Goole, the United Kingdom.